TY  - CHAP
M1  - Book, Section
TI  - Lymphoma, Non-Hodgkin: CD30-Positive Peripheral T-Cell Lymphoma Regimen: Brentuximab Vedotin + Cyclophosphamide + Doxorubicin + Prednisone (A+CHP)
A1  - Therapy, Hematology-Oncology
A2  - Boyiadzis, Michael M.
PY  - 2016
T2  - Hematology-Oncology Therapy Updates
AB  - 
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2022/06/29
UR  - hemonc.mhmedical.com/updatesContent.aspx?gbosid=479159
ER  -